Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Protein > Siglec-2 > CD2-H52H8

Human Siglec-2 / CD22 Protein, His Tag (MALS verified) DMF

Order Now

  • Synonym
    CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,SIGLEC2FLJ22814
  • Source
    Human Siglec-2, His Tag(CD2-H52H8) is expressed from human 293 cells (HEK293). It contains AA Asp 20 - Arg 687 (Accession # P20273-1).
    Predicted N-terminus: Asp 20
  • Molecular Characterization
    Siglec-2 Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 77.0 kDa. The protein migrates as 90-116 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 6 months under sterile conditions after reconstitution.
SDS-PAGE
Siglec-2 SDS-PAGE

Human Siglec-2, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

SEC-MALS
Siglec-2 MALS images

The purity of Human Siglec-2, His Tag (Cat. No. CD2-H52H8) is more than 90% and the molecular weight of this protein is around 100-125 kDa verified by SEC-MALS.

Bioactivity-ELISA
 Siglec-2 ELISA

Immobilized Human Siglec-2, His Tag (Cat. No. CD2-H52H8) at 2 μg/mL (100 μL/well) can bind Anti-Human CD22 MAb with a linear range of 0.3-5 ng/mL (QC tested).

 Siglec-2 ELISA

Immobilized Human Siglec-2, His Tag (Cat. No. CD2-H52H8) at 2 μg/mL, add increasing concentrations of anti-CD22xCD19 scFv and then add Biotinylated Human CD19 (20-291), Fc,Avitag at 0.2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 3.9 ng/mL (Routinely tested).

Bioactivity-BLI
 Siglec-2 BLI

Loaded Anti-Human CD22 MAb (human IgG1) on AHC Biosensor, can bind Human Siglec-2, His Tag (Cat. No. CD2-H52H8) with an affinity constant of 133 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Evaluation of CAR expression
FACS Analysis of Anti-CD22 CAR Expression
 Siglec-2 CAR_T

293 cells were transfected with anti-CD22-scFv and RFP tag. 2e5 of the cells were first stained with B. Human Siglec-2, His Tag (Cat. No. CD2-H52H8, 3 μg/mL) and C. His Tag Protein Control, followed by FITC Anti-6xHis Tag Antibody. A. Non-transfected 293 cells and C. His Tag Protein Control were used as negative control. RFP was used to evaluate CAR (anti-CD22-scFv) expression and FITC was used to evaluate the binding activity of Human Siglec-2, His Tag (Cat. No. CD2-H52H8).

  • Background
    B-cell receptor CD22 is also known as Sialic acid-binding Ig-like lectin 2 (Siglec-2), B-lymphocyte cell adhesion molecule (BL-CAM), T-cell surface antigen Leu-14, which belongs to the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. CD22 mediates B-cell B-cell interactions, and may be involved in the localization of B-cells in lymphoid tissues. Siglec-2 / CD22 binds sialylated glycoproteins, one of which is CD45. Siglec2 / CD22 plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules.
  • Clinical and Translational Updates

Comments (0)


ETA of in-stock products: 2 business days

Price(USD) : $290.00

Price(USD) : $2200.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:2 Details
  • Number of Drugs in Clinical Trials:62 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message